CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-15 | Clark Mitchall G. EVP & Chief R & QA Officer | Shares withheld for taxes | −3,604 | $47.05 | $170K | 183,520 |
| 2018-02-15 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise · Restricted Stock Units | −7,211 | 4,808 | ||
| 2018-02-15 | Soffer Gad EVP & Chief Strategy Officer | Option exercise | +2,764 | 268,344 | ||
| 2018-02-15 | Soffer Gad EVP & Chief Strategy Officer | Shares withheld for taxes | −1,456 | $47.05 | $69K | 266,888 |
| 2018-02-15 | Soffer Gad EVP & Chief Strategy Officer | Option exercise · Restricted Stock Units | −2,764 | 0 | ||
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −6,500 | $46.77 | $304K | 99,056 |
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +5,132 | 104,188 | ||
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Shares withheld for taxes | −2,926 | $47.05 | $138K | 101,262 |
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −5,132 | 0 | ||
| 2018-02-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,500 | $45.58 | $114K | 260,378 |
| 2018-02-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,433 | $46.71 | $114K | 257,945 |
| 2018-02-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,767 | $47.56 | $227K | 253,178 |
| 2018-02-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −300 | $48.25 | $14K | 252,878 |
| 2018-02-15 | Ciechanover Isaac E. Chief Executive Officer | Option exercise | +3,938 | 812,613 | ||
| 2018-02-15 | Ciechanover Isaac E. Chief Executive Officer | Option exercise · Restricted Stock Units | −3,938 | 0 | ||
| 2018-02-14 | Ciechanover Isaac E. Chief Executive Officer | Sale | −100 | $45.05 | $5K | 272,778 |
| 2018-02-14 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,000 | $46.94 | $47K | 271,778 |
| 2018-02-14 | Ciechanover Isaac E. Chief Executive Officer | Sale | −5,800 | $48.42 | $281K | 265,978 |
| 2018-02-14 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,100 | $49.25 | $153K | 262,878 |
| 2018-02-13 | Ciechanover Isaac E. Chief Executive Officer | Sale | −10,000 | $45.10 | $451K | 272,878 |
Page 35 of 44 · 867 trades